| CVNA |
Report |
Retail Units Sold |
BEAT |
pred ~214,000 units vs. cons ~208,000 units |
MEDIUM |
| CVNA |
Report |
Adjusted EBITDA |
BEAT |
pred ~$755M vs. cons ~$725M |
MEDIUM |
| CVNA |
Report |
GAAP EPS |
BEAT |
pred ~$0.46 vs. cons ~$0.42 |
MEDIUM |
| CVNA |
Guide |
Q3 2026 Retail Unit Growth |
BETTER |
guide ~225,000 units vs. cons ~215,000 units (Q3 2026) |
LOW |
| CVNA |
Guide |
Q3 2026 Adjusted EBITDA Margin |
BETTER |
guide ~10.8% vs. cons ~10.3% (Q3 2026) |
LOW |
| CVNA |
Guide |
FY2026 Adjusted EBITDA Margin Path (toward 13.5% target) |
UNCHANGED |
guide ~11.0% exit-rate trajectory vs. cons ~10.7% (FY2026) |
LOW |
| CVNA |
Return |
Day-1 residual (stock − beta × S&P 500) |
+5.0% |
— |
MEDIUM |
| CVNA |
Return |
5-day cumulative residual |
+3.0% (STABILIZE) |
Operational beat on units/EBITDA is largely pre-guided by management's explicit 'sequential record' language, so the surprise magnitude is modest relative to a stock already priced for continued hyper-growth; initial pop from confirming GPU/reconditioning fix and normalizing wholesale-retail spread gets partially offset by tougher H2 comps (Q3/Q4 2025 margins were strong) and lingering litigation/governance overhang (Gotham allegations, Arizona class action document production) that caps follow-through buying without triggering a full reversal, leaving the stock to consolidate near its post-print level over the following days. |
LOW |